<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-FBQDYVWY/05f73af6-adc6-41b6-8fea-f0bbcf9d8552/PDF"><dcterms:extent>130 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-FBQDYVWY/006a778a-ae2a-4298-8a60-f9aab74bbfed/TEXT"><dcterms:extent>28 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1994-2025"><edm:begin xml:lang="en">1994</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-FBQDYVWY"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-46R7GGHL" /><dcterms:issued>2010</dcterms:issued><dc:creator>Orel, Rok</dc:creator><dc:format xml:lang="sl">številka:4</dc:format><dc:format xml:lang="sl">letnik:49</dc:format><dc:format xml:lang="sl">str. 479-485</dc:format><dc:identifier>ISSN:0025-8121</dc:identifier><dc:identifier>COBISSID:28092889</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-FBQDYVWY</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Medicinski razgledi</dc:publisher><dcterms:isPartOf xml:lang="sl">Medicinski razgledi</dcterms:isPartOf><dc:subject xml:lang="en">Colonic Diseases, Functional</dc:subject><dc:subject xml:lang="sl">črevesje</dc:subject><dc:subject xml:lang="sl">debelo črevo</dc:subject><dc:subject xml:lang="sl">Debelo črevo, bolezni funkcionalne</dc:subject><dc:subject xml:lang="en">Diagnosis</dc:subject><dc:subject xml:lang="en">diagnostika</dc:subject><dc:subject xml:lang="sl">funkcionalne motnje</dc:subject><dc:subject xml:lang="sl">motnje</dc:subject><dc:subject xml:lang="sl">patofiziologija</dc:subject><dc:subject xml:lang="en">Physiopathology</dc:subject><dc:subject xml:lang="en">Therapy</dc:subject><dc:subject xml:lang="sl">zdravljenje</dc:subject><dc:subject rdf:resource="http://www.wikidata.org/entity/Q9639" /><dcterms:temporal rdf:resource="1994-2025" /><dc:title xml:lang="sl">Sindrom razdražljivega črevesja| Irritable bowel syndrome|</dc:title><dc:description xml:lang="sl">Irritable bowel syndrome (lES) is a functional bowel disorder characterized byabdominal pain or discomfort with altered frequency of defecation and stool consistency. Some people with lES also experience urgency for bowel movements,feeling of incomplete sto ol evacuation, straining and cramping during defecation, presence of mucus in sto ol, abdominal disten ti on and flatulence. lES is believed to be the consequence of several factors: altered bowel motility and sensitivity (visceral hypersensitivity), altered brain-gut axis function, low-grade mucosal inflammation, disturbed balance of intestinalmicrobiota, chemical irritation, action of psychogenic factors and (at least in some case s) genetic predisposition. When there are no alarm signs, the diagnosis of lES can be made on the basis of clinical presentation alone. When alarm signs, such as rectal bleeding, fever, high erythrocyte sedimentation rate, weight loss, failure to thrive (children) or positive family history for organic bowel disease (chronic inflammatory bowel disease, cancer) are present, accurate diagnostics is necessary. When treating patiems with IBS, education and a trustful patient-doctor relationship are necessary, with emphasis on IBS being a benign disorder that only rarely leads to seriousconsequences.Some patients benefit from excluding nutrients that are known to cause discomfort from their dieto However, most patients do not need a specific dieto Special probiotics having effects validated by high-quality clinical trials may be useful in treating patients with IBS. When memal factors play an important part, psycho therapy mayaIso have a role. The use ofmedications, however, is reserved only for resistant forms of IBS</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-FBQDYVWY"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-FBQDYVWY" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-FBQDYVWY/05f73af6-adc6-41b6-8fea-f0bbcf9d8552/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo Medicinski razgledi</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-FBQDYVWY/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-FBQDYVWY" /></ore:Aggregation></rdf:RDF>